Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Blood regulation and safety
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Drug Analysis Prints (DAPs)
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Press release
Taking multiple medicines? Support the Yellow Card scheme by reporting suspected side effects
The Medicines and Healthcare products Regulatory Agency (MHRA) launches a week long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.
Press release
Strengthened recommendations for the yellow fever vaccine
The Commission on Human Medicines recommends further precautions for people with weakened immunity and in those aged 60 years or older.
Press release
MHRA drug alert: recalls for 13 over-the-counter Ranitidine medicines
A drug alert has been issued to retailers and healthcare professionals as 4 companies are recalling batches of certain over-the-counter Ranitidine medicines used to treat conditions such as stomach ulcers and heartburn.
Press release
Emerade pens – patients reminded to carry 2 pens at all times
Patients who carry Emerade auto-injector pens for the emergency treatment of severe acute allergic reactions (anaphylaxis) to foods, medicines or insect stings are being reminded of existing advice to carry 2, in-date pens with them - at all times.
News story
MHRA update on novel coronavirus (COVID-19)
The MHRA is working closely with the DHSC and others in the global response to the new Coronavirus (COVID-19)
Latest from the Medicines and Healthcare products Regulatory Agency
- All T34 and T34L (T60) ambulatory syringe pumps – check pumps before each use due to risk of under-infusion and no alarm (MDA/2020/007)
- Medicines that cannot be parallel exported from the UK
- Class 4 Medicines Defect Information: Memantine 10mg Film-Coated Tablets, PL 20416/0260, (EL (20)A/11)
Subscriptions
Subscribe to feed
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
News and communications
See all news and communicationsPolicy papers and consultations
- MHRA consultation on EU exit no-deal legislative proposals
- How should we engage and involve patients and the public in our work
Transparency and freedom of information releases
See all transparency and freedom of information releasesOur management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
Corporate information
Jobs and contracts